Fetal cardiology is a specialized field of medicine that focuses on the diagnosis and management of heart-related issues in the developing fetus. This branch of cardiology has gained prominence due to advancements in prenatal imaging technologies, allowing healthcare professionals to assess the fetal heart as early as the first trimester. Fetal echocardiography, a non-invasive ultrasound technique, plays a crucial role in detecting congenital heart defects and abnormalities in the unborn child. Early detection is vital for timely intervention and improved outcomes. Fetal cardiology involves collaboration between obstetricians, pediatric cardiologists, and other healthcare specialists to provide comprehensive care for both the mother and the unborn child. With a multidisciplinary approach, fetal cardiology aims to enhance prenatal diagnosis, counseling, and treatment strategies, ensuring a better quality of life for infants born with congenital heart conditions. The field continues to evolve, contributing to advancements in fetal medicine and ultimately fostering healthier pregnancies and births.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India